Where do we go from Here? Prevalence of trachoma three years after stopping mass distribution of antibiotics in the regions of Kayes and Koulikoro, Mali

PLoS Neglected Tropical Diseases

Volumn 4, Issue 7, 2010, Pages

  Bamani, Sanoussi ^a   King, Jonathan D ^b   Dembele, Mamadou ^a   Coulibaly, Famolo ^a   Sankara, Dieudonne ^c   Kamissoko, Yaya ^b   Ting, Jim ^b   Rotondo, Lisa A ^d   Emerson, Paul M ^b  

^a Programme National de Lutte Contre la Schistosomiase   (Mali)

^b CARTER CENTER   (United States)

^c RTI INTERNATIONAL   (United States)

^d International Trachoma Initiative   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CHILD HEALTH; CLINICAL DECISION MAKING; CLUSTER ANALYSIS; COMMUNITY ASSESSMENT; COMMUNITY CARE; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PLANNING; HEALTH PROMOTION; HEALTH SURVEY; HUMAN; HYGIENE; INFECTION CONTROL; INTERVENTION STUDY; MAJOR CLINICAL STUDY; MALE; MALI; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRACTICE GUIDELINE; PRESCHOOL CHILD; PREVALENCE; SCHOOL CHILD; TRACHOMA; AGED; ENDEMIC DISEASE; INFANT; METHODOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; COMMUNICABLE DISEASE CONTROL; ENDEMIC DISEASES; FEMALE; HUMANS; INFANT; MALE; MALI; MIDDLE AGED; PREVALENCE; TRACHOMA; YOUNG ADULT;

EID: 77957890451     PISSN: None     EISSN: None     Source Type: Journal    
DOI: 10.1371/journal.pntd.0000734     Document Type: Article

References (30)

1. Mariotti SP, Pascolini D, Rose-Nussbaumer J (2008) Trachoma: global magnitude of a preventable cause of blindness. Br J Ophthalmol 93: 563-568. doi:10.1136/bjo.2008.148494.
2. World Health Organization (2006) Trachoma Control: A guide for program managers. Geneva.
3. Thylefors B, Dawson CR, Jones BR, West SK, Taylor HR (1987) A simple system for the assessment of trachoma and its complications. Bull World Health Organ 65: 477-83.
4. Schémann JF, Sacko D, Banou A, Bamani S, Boré B, et al. (1998) Cartographie du trachoma au Mali: résultants d'une enquête nationale. Bull World Health Organ 76: 599-606.
5. Lemshow S, Robinson D (1985) Surveys to measure programme coverage and impact: a review of the methodology used by the Expanded Programme on Immunization. World Health Statistics Quarterly 38: 65-75.
6. Turner AG, Magnani RJ, Shuaib M (1996) A not quite as quick but much cleaner alternative to the Expanded Programme on Immunization (EPI) cluster survey design. International Journal of Epidemiology 25: 198-03.
7. Woodruff R (1971) A simple method for approximating the variance of a complicated estimate. Journal of the American Statistical Association. pp 411-14.
8. SAS Institute Inc (2004) SAS Online DocH 9.1.3. Cary, NC.
9. Resnikoff S, Huguet P, Mariotti SP (2007) Certification of the elimination of blinding trachoma by the World Health Organization. Revue internationale du Trachome et de Pathologie Oculaire Tropicale et Subtropicle et de Sante Publique 84: 59-68.
10. United Nations Development Programme. Millennium Development Goal 7; Indicator 7.9, Proportion of population using an improved sanitation facility (2007) Available from URL: http://www.mdgmonitor.org/goal7.cfm accessed on 12th August 2009.
11. Cromwell EA, Ngondi J, Gatpan G, Becknell S, Kur L, et al. (2009) Estimation of population coverage for antibiotic distribution for trachoma control: a comparison of methods. International Health 1: 182-189.
12. Taylor H (2008) Will trachoma disappear before we eliminate it? In Trachoma, a blinding scourge from the bronze age to the twenty-first century. Melbourne, Australia: Center for Eye Health Australia. pp 217-242.
13. Dolin P, Faal H, Johnson G, Minassian D, Sowa S, Day S, et al. (1997) Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet 350: 447-448.
14. Hoechsmann A, Metcalfe N, Kanjaloti S, Godia H, Mtambo O, et al. (2001) Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol 8: 145-53.
15. Jha H, Chaudary JS, Bhatta R, Miao Y, Osaki-Holm S, et al. (2002) Disappearance of trachoma from Western Nepal. Clin Infect Dis 35: 765-8.
16. Bamani S, Dembele M, Sankara D, Coulibaly F, Kamissoko Y, et al. (2010) Evaluation of the prevalence of trachoma 12 years after baseline surveys in Kidal Region, Mali. Tropical Medicine and International Health 15: 306-311.
17. Ray KJ, Porco T, Hong KC, Lee DC, Alemayehu W, et al. (2007) A rationale for continuing mass antibiotic distributions for trachoma. BMC Infectious Diseases 7: 91.
18. Lakew T, Alemayehu W, Melese M, Yi E, House J, et al. (2009) Importance of coverage and endemicity on the return of infectious trachoma after a single mass antibiotic distribution. PLoS Negl Trop Dis 3: 8 e507.
19. Lakew T, House J, Hong KC, Yi E, Alemayehu W, et al. (2009) Reduction and return of infectious trachoma in severely affected communities in Ethiopia. PLoS Negl Trop Dis 3: 2 e376.
20. Cromwell EA, Courtright P, King JD, Rotondo LA, Ngondi J, et al. (2009) The excess burden of trachomatous trichiasis in women: a systematic review and meta-analysis. Trans R Soc Trop Med Hyg 103: 985-992. doi:10.1016/ j.trstmh.2009.03.012.
21. Hägi M, Schémann JF, Mauny F, Momo G, Sacko D, et al. (2010) Active trachoma among children in Mali: Clustering and environmental risk factors. PLoS Negl Trop Dis 4: e583.
22. Emerson PM, Ngondi J (2009) Mass antibiotics treatment alone does not eliminate ocular chlamydial infection. PLoS Negl Trop Dis 3: e394. doi:10.1371/journal.pntd.0000394.
23. Burton MJ, Holland MJ, Faal N, Aryee EA, Alexander ND, et al. (2003) Which members of a community need antibiotics to control trachoma? Conjunctival Chlamydia trachomatis infection load in Gambian villages. Invest Ophthalmol Vis Sci 44: 4215-22.
24. Harding-Esch EM, Edwards T, Sillah A, Sarr I, Roberts CH, et al. (2009) Active trachoma and ocular Chlamydia trachomatis infection in two Gambian regions: on course for elimination by 2020? PLoS Negl Trop Dis 3: 12 e573.
25. Thein J, Zhao P, Liu H, Xu J, Jha H, et al. (2002) Does clinical diagnosis indicate ocular chlamydial infection in areas with a low prevalence of trachoma? Ophthalmic Epidemiol 9: 263-269.
26. Lietman TM, Dawson CR, Osaki SY, Zegans ME (2000) Clinically active trachoma versus actual Chlamydial infection. Med J Aust 172: 93-94.
27. West SK, Munoz B, Mkocha H, Hsieh YH, Lynch MC (2001) Progression of active trachoma to scarring in a cohort of Tanzanian children. Ophthalmic Epidemiol 8: 137-144.
28. West SK, Munoz B, Mkocha H, Holland MJ, Solomon AW, et al. (2005) Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 366: 1296-1300.
29. Yayemain D, King JD, Debrah O, Emerson PM, Aboe A, et al. (2009) Achieving trachoma control in Ghana after implementing the SAFE strategy. Trans R Soc Trop Med Hyg 103: 993-1000. doi:10.1016/j.trstmh.2009.02.007.
30. Ngondi J, Matthews F, Reacher M, Baba S, Brayne C, et al. (2008) Associations between Active Trachoma and Community Intervention with Antibiotics, Facial Cleanliness, and Environmental Improvement (A,F,E). PLoS Negl Trop Dis 2: e229.